STC
INSY

SEI Trust Company’s Insys Therapeutics, Inc. INSY Stock Holding History

SEI Trust Company’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$798K Sell
41,134
-70
-0.2% -$1.1K 0.01% 974
2014
Q2 		$643K Sell
41,204
-2
-0% -$32 0.01% 1034
2014
Q1 		$854K Buy
41,206
+6,712
+19% +$133K 0.01% 957
2013
Q4 		$445K Buy
+34,494
New +$478K ﹤0.01% 1172

Other funds holding INSY

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BTP
Bloom Tree Partners New York $215M AUM 17.45% 1-Year Est. Return

SEI Trust Company's INSY Position: Q3 2014 in Review

SEI Trust Company reduced its Insys Therapeutics, Inc. (INSY) stake by 0.17% in Q3 2014, selling an estimated $1.1K and leaving 41,134 shares worth $798K. The position accounts for 0.01% of the portfolio, ranked #974.

SEI Trust Company first reported a position in INSY in Q4 2013 and has held it in 4 quarters since. The position peaked at $854K in Q1 2014. 111 funds tracked by Wall St. Rank hold INSY as of Q3 2014.

  • SEI Trust Company held 41,134 shares of Insys Therapeutics, Inc. worth $798K as of Q3 2014.
  • SEI Trust Company sold 70 Insys Therapeutics, Inc. shares in Q3 2014, an estimated $1.1K.
  • Insys Therapeutics, Inc. made up 0.01% of SEI Trust Company's portfolio in Q3 2014, its #974 holding.
  • SEI Trust Company first reported a position in Insys Therapeutics, Inc. in Q4 2013 and has held it in 4 quarters since.
  • SEI Trust Company's Insys Therapeutics, Inc. position peaked at $854K in Q1 2014.
  • 111 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.